Kevin Smith, CFA, Founder and CEO of Crescat Capital, commented: "High-purity manganese sulfate monohydrate (HPMSM) demand is expected to increase 29x by 2050 because it's critical for electric ...

a split dose of sulfate-based tablets may be a good alternative to a split-dose sulfate-based solution. A split-dose sulfate-based tablet was found to be noninferior to a split-dose sulfate-based ...